Leaders of the pack - Roche, Allergan, Novo, Biogen Idec and Shire?
This article was originally published in Scrip
The next wave of leaders in the pharmaceutical industry could be headed by Allergan, Biogen Idec, Novo Nordisk and Shire, according to a report published today by Goldman Sachs, which analysed what strategies companies need to employ to be successful in current and upcoming market conditions and which companies are nearest the mark.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.